A virtual Experts Knowledge Share on the topic ‘Targeting Advanced Prostate Cancer with PARP inhibitors' : Who, When and How?’ chaired by Prof. Fred Saad (Canada) and co-chaired by Assoc. Prof. Tanya Dorff (USA) and Prof. Gerhardt Attard (UK).

Learn about and discuss how to:

1. Recognise the efficacy and safety profiles of PARP inhibitors for patients with prostate cancer, including an overview of the data in other tumour types
2. Be able to implement testing strategies to predict if the prostate cancer is likely to respond to a PARP inhibitor or some other treatment
3. Understand the data of combination studies with PARP inhibitors, the appropriate implementation in treatment strategies and the impact on clinical practice

You will also have the opportunity to contribute to the discussion on this important topic in genitourinary oncology and present your own patient case studies.  If you would like to submit a case study, please send this to sam.brightwell@cor2ed.com.